|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$42.30 |
$42.39 |
$42.09 |
$42.19 |
707.40K | 03/25/2024 |
$42.20 |
$42.45 |
$42.20 |
$42.40 |
1.56M | 03/26/2024 |
$42.48 |
$42.60 |
$42.23 |
$42.36 |
1.30M | 03/27/2024 |
$42.36 |
$42.52 |
$42.18 |
$42.38 |
889.40K | 03/28/2024 |
$42.35 |
$42.38 |
$42.11 |
$42.27 |
1.06M |
|
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. | |
|
Cerevel Therapeutics Holdings (CERE) has the following price history information. Looking back at CERE historical stock prices for the last five trading days, on March 22, 2024, CERE opened at $42.30, traded as high as $42.39 and as low as $42.09, and closed at $42.19. Trading volume was a total of 707.40K shares. On March 25, 2024, CERE opened at $42.20, traded as high as $42.45 and as low as $42.20, and closed at $42.40. Trading volume was a total of 1.56M shares. On March 26, 2024, CERE opened at $42.48, traded as high as $42.60 and as low as $42.23, and closed at $42.36. Trading volume was a total of 1.30M shares. On March 27, 2024, CERE opened at $42.36, traded as high as $42.52 and as low as $42.18, and closed at $42.38. Trading volume was a total of 889.40K shares. On March 28, 2024, CERE opened at $42.35, traded as high as $42.38 and as low as $42.11, and closed at $42.27. Trading volume was a total of 1.06M shares.
CERE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cerevel Therapeutics Holdings shares, starting with a $10,000 purchase of CERE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/31/2020 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$11.20 |
|
End price/share: |
$42.27 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
277.41% |
|
Average Annual Total Return: |
43.74% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$37,737.87 |
|
Years: |
3.66 |
|
|
|
Date |
Close |
03/22/2024 | $42.19 | 03/25/2024 | $42.40 | 03/26/2024 | $42.36 | 03/27/2024 | $42.38 | 03/28/2024 | $42.27 |
|
|